Parkinson’s boost in €10bn EU funding round

Europe

Author: George TheohariPublished: 29 July 2015

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

EU announces investment in new treatments for Parkinson’s

Parkinson’s will be one of the main health areas to benefit from funding under the European Investment Bank’s (EIB) latest investment round.

The EIB – the EU’s long-term lending institution – has approved €10 billion of loans for a variety of strategic projects around the world.

These include medical research into Parkinson’s and epilepsy, as well as a host of infrastructure projects and investment in corporate research in the energy, automobile, and textile sectors.

Details of the investment in Parkinson’s have yet to be announced, but previously the EIB has provided funds for the development of new treatments by the Portuguese pharmaceutical company Bial.

In 2010-13 the EIB committed €50 million in loans to Bial’s research and development activities on drugs for epilepsy, cardiovascular affections and Parkinson’s disease.

Go Back

Share this story

Comments


Related articles


sponsored article

Perspectives

“I love my life, even with Parkinson’s disease”

How DBS helped Inge Carstensen learn to live with Parkinson's

READ MORE
Rosemarie Wilson stress-free life

Health & Fitness

9 steps to a stress-free life with Parkinson’s

How to improve your quality of life in 9 easy steps

READ MORE
The UK Parkinson's Football Team

Interviews

The road to Copenhagen: The UK Parkinson’s Football Team

We talk to team captain Charlie Appleyard

READ MORE